Annual Current Liabilities
$27.41 M
+$8.28 M+43.26%
December 1, 2024
Summary
- As of February 25, 2025, VKTX annual total current liabilities is $27.41 million, with the most recent change of +$8.28 million (+43.26%) on December 1, 2024.
- During the last 3 years, VKTX annual current liabilities has risen by +$18.64 million (+212.29%).
- VKTX annual current liabilities is now at all-time high.
Performance
VKTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$27.41 M
+$1.73 M+6.73%
December 1, 2024
Summary
- As of February 25, 2025, VKTX quarterly total current liabilities is $27.41 million, with the most recent change of +$1.73 million (+6.73%) on December 1, 2024.
- Over the past year, VKTX quarterly current liabilities has stayed the same.
- VKTX quarterly current liabilities is now -16.36% below its all-time high of $32.77 million, reached on March 31, 2024.
Performance
VKTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
VKTX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +43.3% | 0.0% |
| 3 y3 years | +212.3% | +212.3% |
| 5 y5 years | +304.5% | +304.5% |
VKTX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +212.3% | -16.4% | +212.3% |
| 5 y | 5-year | at high | +304.5% | -16.4% | +304.5% |
| alltime | all time | at high | >+9999.0% | -16.4% | +6183.1% |
Viking Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $27.41 M(+43.3%) | $27.41 M(+6.7%) |
| Sep 2024 | - | $25.68 M(+2.4%) |
| Jun 2024 | - | $25.09 M(-23.4%) |
| Mar 2024 | - | $32.77 M(+71.3%) |
| Dec 2023 | $19.14 M(-12.8%) | $19.14 M(+42.7%) |
| Sep 2023 | - | $13.40 M(-0.5%) |
| Jun 2023 | - | $13.48 M(-13.9%) |
| Mar 2023 | - | $15.65 M(-28.7%) |
| Dec 2022 | $21.95 M(+150.0%) | $21.95 M(+56.1%) |
| Sep 2022 | - | $14.06 M(-5.4%) |
| Jun 2022 | - | $14.86 M(+31.9%) |
| Mar 2022 | - | $11.27 M(+28.4%) |
| Dec 2021 | $8.78 M(-27.6%) | $8.78 M(-22.7%) |
| Sep 2021 | - | $11.35 M(-11.8%) |
| Jun 2021 | - | $12.87 M(-0.3%) |
| Mar 2021 | - | $12.92 M(+6.5%) |
| Dec 2020 | $12.13 M(+79.0%) | $12.13 M(+24.8%) |
| Sep 2020 | - | $9.71 M(+7.3%) |
| Jun 2020 | - | $9.05 M(+6.0%) |
| Mar 2020 | - | $8.54 M(+26.0%) |
| Dec 2019 | $6.78 M | $6.78 M(+9.4%) |
| Sep 2019 | - | $6.19 M(+10.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $5.63 M(+14.4%) |
| Mar 2019 | - | $4.92 M(+8.1%) |
| Dec 2018 | $4.55 M(-47.4%) | $4.55 M(-4.1%) |
| Sep 2018 | - | $4.74 M(+15.5%) |
| Jun 2018 | - | $4.11 M(-35.2%) |
| Mar 2018 | - | $6.34 M(-26.8%) |
| Dec 2017 | $8.66 M(+33.7%) | $8.66 M(-9.9%) |
| Sep 2017 | - | $9.61 M(+24.4%) |
| Jun 2017 | - | $7.73 M(+128.5%) |
| Mar 2017 | - | $3.38 M(-47.8%) |
| Dec 2016 | $6.48 M(+227.6%) | $6.48 M(+6.6%) |
| Sep 2016 | - | $6.08 M(+5.9%) |
| Jun 2016 | - | $5.74 M(+199.2%) |
| Mar 2016 | - | $1.92 M(-3.0%) |
| Dec 2015 | $1.98 M(-91.2%) | $1.98 M(-65.5%) |
| Sep 2015 | - | $5.72 M(+17.4%) |
| Jun 2015 | - | $4.88 M(-82.4%) |
| Mar 2015 | - | $27.71 M(+23.1%) |
| Dec 2014 | $22.52 M(>+9900.0%) | $22.52 M(-6.1%) |
| Jun 2014 | - | $23.97 M(+5393.5%) |
| Mar 2014 | - | $436.30 K |
| Dec 2013 | $127.50 K(+134.4%) | - |
| Dec 2012 | $54.40 K | - |
FAQ
- What is Viking Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Viking Therapeutics?
- What is Viking Therapeutics annual current liabilities year-on-year change?
- What is Viking Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Viking Therapeutics?
- What is Viking Therapeutics quarterly current liabilities year-on-year change?
What is Viking Therapeutics annual total current liabilities?
The current annual current liabilities of VKTX is $27.41 M
What is the all time high annual current liabilities for Viking Therapeutics?
Viking Therapeutics all-time high annual total current liabilities is $27.41 M
What is Viking Therapeutics annual current liabilities year-on-year change?
Over the past year, VKTX annual total current liabilities has changed by +$8.28 M (+43.26%)
What is Viking Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of VKTX is $27.41 M
What is the all time high quarterly current liabilities for Viking Therapeutics?
Viking Therapeutics all-time high quarterly total current liabilities is $32.77 M
What is Viking Therapeutics quarterly current liabilities year-on-year change?
Over the past year, VKTX quarterly total current liabilities has changed by $0.00 (0.00%)